SSSahar Saraf-Bank

Sahar Saraf-Bank

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sahar Saraf-Bank has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effects of pomegranate peel powder-fortified bread consumption in patients with type 2 diabetes mellitus: randomized controlled trial

    by Maryam Zare, Atefe Rezaei, Mozhgan Karimifar, Mohammad Javad Tarrahi, Sahar Saraf-Bank, Sayed Amir Hossein Goli, Reza Amani

    Objectives Type 2 diabetes mellitus (T2DM) poses a huge global disease burden due to high morbidity and mortality rates. Dietary modifications can significantly regulate T2DM risk factors. This study primarily aimed to investigate the effects of bread fortified with pomegranate peel powder (PPP) on glycemic control, lipid profile, and anthropometric measures in patients with T2DM. Methods PPP was added to bread by adding 0, 1.5, 2.5, 3.5, and 5% PPP. We measured the phenol content by Folin-Ciocalteu and the antioxidant activity via DPPH (2,2-diphenyl-1-picrylhydrazyl). Ninety participants were then allocated to a randomized parallel controlled intervention study, and the effects of consuming 100 g/day of bread with PPP (3.5%) on glycemic markers, lipid profiles, and anthropometrics were assessed. The bread administered to the control group was the same as that used for the intervention group except for the absence of PPP. Results The PPP-fortified bread contained greater polyphenol levels and antioxidant activity than the bread without PPP. Compared to the control bread, fortified bread with PPP showed no significant effects on anthropometric measures, blood pressure, glycemic levels, and lipid markers after adjusting for age, sex, and caloric intake. Conclusions In comparison with control bread, PPP bread does not show much effect on glycemic parameters, lipid profile, and anthropometric measurements. Extended duration, different doses, and larger sample sizes are advisable for further studies. Trial registration IRCT20191209045672N1 is the trial ID in the Iranian Registry of Clinical Trials. Date of registration 21/09/2020. https//en.irct.ir/trial/48,132.


  • Open Access

    Elevated risk of possible sarcopenia and weak muscle strength with higher dietary inflammatory index in Iranian breast cancer survivors: a cross-sectional study

    by Kianaz Shirinyfard Pilehrood, Gholamreza Askari, Mehran Sharifi, Mehdi Kargarfard, Sahar Saraf-Bank

    Increased levels of inflammation in cancer patients and survivors can make them more prone to muscle wasting and sarcopenia. Diet can be an appropriate treatment for alleviating patient complications. Therefore, this study was performed to determine the association between sarcopenia and its components with the dietary inflammatory index (DII) among breast cancer survivors. A total of 223 female breast cancer survivors were included in this research at the Cancer Prevention Research Center of Seyyed Al-Shohada Hospital and the Iranian Cancer Control Charity Institute (MACSA). Forty-three items of dietary inflammatory index (DII) were extracted from the Food Frequency Questionnaire. Sarcopenia detection was performed according to the Asian criteria. The linear and binary logistic regression was used to assess the association between sarcopenia and its components with DII. Participants in the highest DII quartile had significantly elevated risk of impaired hand grip strength and calf circumference in both crude and adjusted models. Moreover, individuals consuming a more pro-inflammatory diet displayed a greater risk of abnormal appendicular skeletal muscle index in the crude model. After controlling for potential confounders, participants in the top quartile of DII had a 2.992-fold greater risk of possible sarcopenia than those in the bottom quartile (P value = 0.035). In addition, a decreasing linear trend was observed between higher DII score and 0.059 and 0.349- units lower in appendicular skeletal muscle mass index and hand grip strength variables in the crude Model (P-value < 0.05). Diets with more pro-inflammatory features might be associated with increased risk of possible sarcopenia, as well as its components especially muscle mass and strength in women recovering from breast cancer.


  • Open Access

    Appetite sensation improvement by synbiotic supplementation in patients with metabolic syndrome: A randomized controlled clinical trial

    by Fatemeh Hosseini, Mahboube Pourjam, Soheila Mirzaeian, Mozhgan Karimifar, Awat Feizi, Mohammad Hassan Entezari, Sahar Saraf‐Bank

    The potential link between dysbiosis, features of metabolic syndrome (MetS), inflammation, and sensation impairment has been recently recognized. However, in this context, there are few indications available regarding the effects of co‐supplementation with Bacillus indicus, Bacillus coagulans, and fructooligosaccharide (FOS) prebiotics on patients with MetS. Therefore, this study aimed to investigate the effects of synbiotic supplementation on glycemic indices, inflammatory biomarkers, and appetite among adults with MetS. This study is a randomized, double‐blind, placebo‐controlled clinical trial conducted in the Endocrine and Metabolism Research Center outpatient clinic in Isfahan, Iran. Fifty‐eight MetS patients were randomly assigned to receive either synbiotics (n = 29) or placebo (n = 29) supplementation twice per day for 8 weeks. Finally, 55 patients were recruited for analyses (28 in the intervention group and 27 in the placebo group). Random permuted blocks and a computer‐generated random number table were used for treatment allocation. No adverse effects were reported during the study. There were no significant differences in glycemic indices and inflammatory markers within‐ and between groups (all p > .05). However, a significant increase in the sensation of fullness was documented in the synbiotic group. In conclusion, the eight‐week treatment did not improve glycemic control and inflammatory markers. Nevertheless, it demonstrated potential efficacy in enhancing participants' appetite sensations, warranting further evaluation in longer intervention periods during future clinical trials.


  • Open Access

    A meta‐analysis of the effect of probiotic administration on age‐related sarcopenia

    by Nafiseh Shokri‐Mashhadi, Fatemeh Navab, Shakila Ansari, Mohammad Hossein Rouhani, Zahra Hajhashemy, Sahar Saraf‐Bank

    Global increase in the prevalence of age‐related diseases, such as sarcopenia, highlights the need of recognizing agents that improve muscle health; however, the evidence synthesis on the impact of probiotic administration on sarcopenia is scarce. To summarize and evaluate findings regarding the effect of supplementation with probiotics on sarcopenia, this meta‐analysis was conducted. Using databases, including PubMed, SCOPUS, ISI–Web of Science, and Cochrane Library, interventional studies were included if they investigate the effect of probiotic administration on at least one of the components of sarcopenia up to 6 October 2022. Risk of bias evaluation was conducted using the Cochrane quality assessment tool. The random‐effects model which takes between‐study variations into account was used to obtain the overall effect sizes. The STATA version 14.0 was used for statistical analyses. Overall, 17 studies were included. There was high certainty of evidence that probiotic supplementation has a beneficial effect on muscle mass (kg) (WMD: 0.55, 95% CI: 0.05, 1.05; I2: 0.0%, p = .995), and muscle function (WMD: 0.13, 95% CI: 0.03, 0.23; I2: 65.6%, p = .05). Moreover, administration of probiotics for more than 12 weeks significantly increased muscle strength (WMD: 1.16, 95% CI: 0.88, 1.44; I2: 0.0%, p = .77). However, probiotic supplementation had no effect on anthropometric indices, including body mass index. Probiotic supplementation could improve muscle mass and muscle function in adults more than 55 years old. The beneficial effect of probiotics on muscle strength could appear after 12 weeks of supplementation.


  • Effects of melatonin supplementation on BDNF concentrations and depression: A systematic review and meta-analysis of randomized controlled trials

    by Nafiseh Shokri-Mashhadi, Mina Darand, Mohammad Hossein Rouhani, Maryam Yahay, Bradley A. Feltham, Sahar Saraf-Bank


  • Effects of folate supplementation on recurrence and metabolic status of cervical intraepithelial neoplasia grade 2/3 in overweight and obese women: a randomized double-blind placebo-controlled trial

    by Sima Sabihi, Zahra Vahedpoor, Sahar Saraf-Bank, Mojgan Nourian

    Background and Objective Inconsistent evidence showed that folate supplementation may be associated with reduced risk of cancer due to improved metabolic profiles and reduced markers of oxidative stress and inflammation. The aim of this investigation was to quantify the effects of folate supplementation on the recurrence and other metabolic factors of women with cervical intraepithelial neoplasia grade 2/3 (CIN2/3). Methods This randomized, double-blind, placebo-controlled clinical trial was performed among 60 overweight/obese women with CIN2/3. Definitive CIN2/3 confirmation was done via biopsy, pathological diagnosis, as well as colposcopy. Participants were randomly assigned to the intervention group to take 5 mg/day folate supplements or placebo group (n = 30 in each group) for 12 weeks. Results The results of the current study showed a non-significant decrease in recurrence of CIN2/3 in the folate group in comparison with the placebo group (3.3% vs. 16.7%, P = 0.08). Compared with the placebo, folate supplementation significantly decreased plasma homocysteine (Hcy) levels (P < 0.001), serum insulin values (in the crude model) (P = 0.01), and homeostasis model assessment of insulin resistance (P = 0.01). Also, folate supplementation resulted in a significant improvement in the quantitative insulin sensitivity check index (P = 0.002) and total antioxidant capacity (P = 0.04) and a significant reduction in high-sensitivity C-reactive protein (P = 0.015) in comparison with the placebo group. Conclusions In conclusion, folate supplementation for 12 weeks among overweight/obese women with CIN2/3 showed a non-significant decrease in its recurrence and had beneficial effects on insulin sensitivity, inflammation, and oxidative stress markers.


  • Open Access

    Effects of curcumin on cardiovascular risk factors in obese and overweight adolescent girls: a randomized clinical trial

    by Sahar Saraf-Bank, Alireza Ahmadi, Zamzam Paknahad, Mohammadreza Maracy, Mojgan Nourian

    KEY WORDS: Curcumin; Adolescent; Diet, reducing; Metabolic syndrome


  • The acidity of early pregnancy diet and risk of gestational diabetes mellitus

    by Sahar Saraf-Bank, Hotav Tehrani, Fahimeh Haghighatdoost, Seyedeh Parisa Moosavian, Leila Azadbakht